The Prevalence of Polypharmacy and Potential Drug-Drug Interactions among Iranian Cancer Patients: Which Patients were at Risk?

Maliheh Sadat BazrafshaniAbbas PardakhtyBehjat Kalantari KhandaniNaser NasiriMasoud MoghaderiAzam BazrafshaniSoheil MehmandoostAmin BeigzadehHamid Sharifi

Published in: Cancer investigation (2022)

Regarding the high prevalence of polypharmacy and potential drug interactions among Iranian cancer patients during chemotherapy courses, it is advisable for physicians, nurses, and pharmacists to be vigilant to improve prescribing patterns. In addition, with intensive monitoring, alternative treatment strategies can be replaced.

Keyphrases

primary care
end stage renal disease
adverse drug
ejection fraction
newly diagnosed
healthcare
mental health
peritoneal dialysis
risk factors
prognostic factors
human health
emergency department
locally advanced
drug induced
climate change
rectal cancer